Original language | English (US) |
---|---|
Pages (from-to) | 2434-2436 |
Number of pages | 3 |
Journal | Journal of Allergy and Clinical Immunology: In Practice |
Volume | 7 |
Issue number | 7 |
DOIs | |
State | Published - Sep 1 2019 |
Funding
This study was funded by the Consortium for Eosinophilic Gastrointestinal Disease Research (CEGIR) (grant no. U54 AI117804) as part of the Rare Disease Clinical Research Network, an initiative of the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), and is cofunded by National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, and NCATS. CEGIR is also supported by patient advocacy groups including the American Partnership for Eosinophilic Disorders, Campaign Urging Research for Eosinophilic Disease, and Eosinophilic Family Coalition.
ASJC Scopus subject areas
- Immunology and Allergy